A meta-analysis study by Dai et al. demonstrates that the administration of VEGF/VEGFR (VEGF receptor) inhibitors had a higher incidence of hypercholesterolemia than controls [20]. The gene discussed is KDR; the disease is Hypercholesterolemia.